Business Wire

MINISTRY-OF-HAJJ-UMRAH

Share
Hajj Expo Slated for January 2023, under the Patronage of Makkah Governor

Under the patronage of H.R.H Prince Khaled Al-Faisal, Advisor to the Custodian of the Two Holy Mosques and Governor of Makkah Region, the Ministry of Hajj and Umrah will be organizing the ‘Hajj Expo 2023’ conference and exhibition, on 9-12 January 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221227005098/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

His Royal Highness Prince Khaled Al-Faisal, Advisor to the Custodian of the Two Holy Mosques, Governor of Makkah Region (Photo: AETOSWire)

The four-day event is part of the Ministry's ongoing efforts to build an innovative ecosystem of services and solutions to better serve pilgrims at the Two Holy Mosques, while enhancing their religious and cultural experiences. It aims to create an integrated and sustainable ecosystem that improves pilgrims’ experiences, anticipate their future trends, and establish opportunities for further collaborations, agreements, and local and international initiatives.

H.E. Minister of Hajj and Umrah, Dr. Tawfiq bin Fawzan Al-Rabiah, said: “The conference will allow entrepreneurs, innovators, and researchers from more than 200 global organizations to share successful experiences, and brainstorm sustainable quality solutions designed to cater to pilgrims’ aspirations and needs. This reflects the unrelenting support dedicated by the Custodian of the Two Holy Mosques, and HH the Crown Prince to the Hajj and Umrah sector, in line with the Saudi Vision 2030.”

With delegations from over 56 countries, ‘Expo Hajj’ is expected to witness the signing of 400 agreements and partnerships. It will feature 10 keynote sessions, 13 panel discussions and ‘Hajj Talks’, as well as 36 workshops and related events and activities, notably the Islamic exposition and the ‘Hajj Hackathon’.

‘Hajj Expo 2023’ will be sponsored by several entities and companies, including Kidana Development Company, Elm, Al Wukalla Company, Catering Contractors Association, Muslim World League, Rua AlMadinah Holding, Motawifs Pilgrims for Southeast Asian Countries Co., Alrajhi Umrah, Dallah Albaraka Holding, Sadu Business Solutions, The Company for Cooperative Insurance (Tawuniya), and Saudi Arabia Railways (SAR), Saudi Public Transport Company (SAPTCO), Mohamed Yousuf Naghi Motors Co., Flynas, Saudi Al-Qaid Transportation Co., Alif Alif FM, High Point Technology Company, and Casablanca Company for Hotel & Touristic Services Co. LTD.

The 2021 edition of the conference saw record numbers with +45,000 attendees and 115 commercial agreements. The second edition will feature a wide range of scientific sessions, workshops, and training programs, with several ministers of Islamic affairs, endowments and Hajj ambassadors and consuls, and Hajj and Umrah operators from around the world.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221227005098/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 14:05:00 CEST | Press release

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for

Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model3.7.2025 12:02:00 CEST | Press release

The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently published in the prestigious International Journal of Molecular Sciences in a joint study conducted by Erlangen University Hospital and Berlin-based drug developer AudioCure. As there is currently no causal treatment for tinnitus, there is a high medical need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702168211/en/ In 10-20% of tinnitus cases, the noise in the ear is so severe that it significantly impairs the quality of life of those affected. (Source: AI-generated) In the current study, AC102 was administered to the middle ear of one experimental group after acoustic trauma, while a second group received a placebo. Although both groups initially showed signs of tinnitus, th

H2SITE Secures EIC Accelerator Funding to Deploy a Flagship 1 TPD Ammonia Cracker Using Membrane Reactor Technology at a Port in North-West Europe3.7.2025 08:40:00 CEST | Press release

H2SITE has been awarded the EIC (European Innovation Council) Accelerator program for a project aimed at deploying a first-of-its-kind ammonia cracking unit capable of producing 1 ton of high-purity hydrogen per day. The system is based on H2SITE’s proprietary palladium-based membrane reactor technology, which enables the simultaneous catalytic decomposition of ammonia and selective hydrogen separation within a single unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702142283/en/ Ammonia Cracker using Membrane Reactor Technology This breakthrough technology offers several compelling advantages over conventional ammonia cracking processes: Lowest Levelized Cost of Hydrogen (LCOH) from ammonia due to high efficiency and integrated operation Reduced energy consumption, operating at significantly lower temperatures (400–450 °C) than traditional cracking methods (typically 600–800 °C) High-purity hydrogen output, compliant

Curve Pay and Thales Join Forces to Securely Transform Digital Wallets on iPhone3.7.2025 08:00:00 CEST | Press release

This collaboration between Curve and Thales provides iOS users with greater control, flexibility, autonomy and digital-security for in-store contactless payments and digital wallets Curve, the ultimate digital wallet, today announced deepening its collaboration with Thales, the global leader in advanced technologies, delivering secure modern payment solutions for financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702696837/en/ Thales D1 Platform to power CURVE PAY (Photo: Thales) This partnership comes on the back of Curve launching Curve Pay on iOS, marking a watershed moment in mobile payments. This partnership is a significant step to reshaping everyday spending, allowing Curve customers to benefit from NFC payment directly in the Curve App for contactless payments in store for all end-users on iOS and Android. Curve Pay is underpinned by Thales’ D1 platform on iOS and Android in Europe which allows

Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment3.7.2025 08:00:00 CEST | Press release

New TBS Osteo Advanced next-generation software enhances fracture risk detection beyond standard of care in osteoporosis, a silent disease affecting over 32 million Europeans1 TBS Osteo Advanced next-generation software to be rolled-out across Europe Broad clinical adoption reinforces TBS Osteo leadership in bone microarchitecture evaluation for fracture risk assessment Subscription-based model offers ongoing services and access to future clinical innovations Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, announces the European launch of its MDR-cleared next-generation TBS Osteo Advanced software. Following the product launch in the United States last month, this next milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702082335/en/ Medimaps' TBS Osteo next-generatio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye